Allelic variations of the vitamin D receptor (VDR) gene are associated with increased risk of coronary artery disease in type 2 diabetics: The DIABHYCAR prospective study

Diabetes and Metabolism

Volumn 39, Issue 3, 2013, Pages 263-270

  Ferrarezi, D A F ^a,b   Bellili Munoz N ^a   Dubois Laforgue, D ^c,d   Cheurfa, N ^a   Lamri, A ^a,d   Reis, A F ^e   Le Feuvre, C ^c   Roussel, R ^a,c,d   Fumeron, F ^a,c   Timsit, J ^c,d   Marre, M ^a,c,d   Velho, G ^a  

^a INSERM   (France)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Coronary artery disease; Type 2 diabetes; VDR gene

Indexed keywords

VITAMIN D RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; PROSPECTIVE STUDIES; RECEPTORS, CALCITRIOL; RISK FACTORS;

EID: 84878753693     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2012.11.004     Document Type: Article

References (40)

1. Haffner S.M., Lehto S., Ronnemaa T., Pyorala K., Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998, 339:229-234.
2. Kannel W.B., McGee D.L. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979, 241:2035-2038.
3. Stamler J., Vaccaro O., Neaton J.D., Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993, 16:434-444.
4. Norman A.W. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 2008, 88:491S-499S.
5. Dobnig H., Pilz S., Scharnagl H., Renner W., Seelhorst U., Wellnitz B., et al. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 2008, 168:1340-1349.
6. Kim D.H., Sabour S., Sagar U.N., Adams S., Whellan D.J. Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). Am J Cardiol 2008, 102:1540-1544.
7. Pilz S., Marz W., Wellnitz B., Seelhorst U., Fahrleitner-Pammer A., Dimai H.P., et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab 2008, 93:3927-3935.
8. Wang T.J., Pencina M.J., Booth S.L., Jacques P.F., Ingelsson E., Lanier K., et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008, 117:503-511.
9. Kasuga H., Hosogane N., Matsuoka K., Mori I., Sakura Y., Shimakawa K., et al. Characterization of transgenic rats constitutively expressing vitamin D-24-hydroxylase gene. Biochem Biophys Res Commun 2002, 297:1332-1338.
10. Bouillon R., Carmeliet G., Verlinden L., van Etten E., Verstuyf A., Luderer H.F., et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008, 29:726-776.
11. Uitterlinden A.G., Fang Y., Van Meurs J.B., Pols H.A., Van Leeuwen J.P. Genetics and biology of vitamin D receptor polymorphisms. Gene 2004, 338:143-156.
12. McDermott M.F., Ramachandran A., Ogunkolade B.W., Aganna E., Curtis D., Boucher B.J., et al. Allelic variation in the vitamin D receptor influences susceptibility to IDDM in Indian Asians. Diabetologia 1997, 40:971-975.
13. Suarez F., Zeghoud F., Rossignol C., Walrant O., Garabédian M. Association between vitamin D receptor gene polymorphism and sex-dependent growth during the first two years of life. J Clin Endocrinol Metab 1997, 82:2966-2970.
14. Hitman G.A., Mannan N., McDermott M.F., Aganna E., Ogunkolade B.W., Hales C.N., et al. Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians. Diabetes 1998, 47:688-690.
15. Ye W.Z., Reis A.F., Dubois-Laforgue D., Bellanne-Chantelot C., Timsit J., Velho G. Vitamin D receptor gene polymorphisms are associated with obesity in type 2 diabetic subjects with early age of onset. Eur J Endocrinol 2001, 145:181-186.
16. Oh J.Y., Barrett-Connor E. Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community-dwelling older adults: the Rancho Bernardo Study. Metabolism 2002, 51:356-359.
17. Reis A.F., Hauache O.M., Velho G. Vitamin D endocrine system and the genetic susceptibility to diabetes, obesity and vascular disease. A review of evidence. Diabetes Metab 2005, 31:318-325.
18. Jain R., von Hurst P.R., Stonehouse W., Love D.R., Higgins C.M., Coad J. Association of vitamin D receptor gene polymorphisms with insulin resistance and response to vitamin D. Metabolism 2012, 61:293-301.
19. Ferrarezi D.A., Bellili-Munoz N., Nicolau C., Cheurfa N., Guazzelli I.C., Frazzatto E., et al. Allelic variations in the vitamin D receptor gene, insulin secretion and parents' heights are independently associated with height in obese children and adolescents. Metabolism 2012, 61:1413-1421.
20. Lievre M., Marre M., Chatellier G., Plouin P., Reglier J., Richardson L., et al. The non-insulin-dependent diabetes, hypertension, microalbuminuria or proteinuria, cardiovascular events, and ramipril (DIABHYCAR) study: design, organization, and patient recruitment. Control Clin Trials 2000, 21:383-396.
21. Marre M., Lievre M., Chatellier G., Mann J.F., Passa P., Menard J. Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study). BMJ 2004, 328:495.
22. Le Feuvre C.L., Barthelemy O., Dubois-Laforgue D., Maunoury C., Mogenet A., Baubion N., et al. Stress myocardial scintigraphy and dobutamine echocardiography in the detection of coronary disease in asymptomatic patients with type 2 diabetes. Diabetes Metab 2005, 31:135-142.
23. Fang Y., van Meurs J.B., d'Alesio A., Jhamai M., Zhao H., Rivadeneira F., et al. Promoter and 3'-untranslated-region haplotypes in the vitamin d receptor gene predispose to osteoporotic fracture: the rotterdam study. Am J Hum Genet 2005, 77:807-823.
24. Tregouet D.A., Escolano S., Tiret L., Mallet A., Golmard J.L. A new algorithm for haplotype-based association analysis: the Stochastic-EM algorithm. Ann Hum Genet 2004, 68:165-177.
25. Ortlepp J.R., Von Korff A., Hanrath P., Zerres K., Hoffmann R. Vitamin D receptor gene polymorphism BsmI is not associated with the prevalence and severity of CAD in a large-scale angiographic cohort of 3441 patients. Eur J Clin Invest 2003, 33:106-109.
26. Monraats P.S., Fang Y., Pons D., Pires N.M., Pols H.A., Zwinderman A.H., et al. Vitamin D receptor: a new risk marker for clinical restenosis after percutaneous coronary intervention. Expert Opin Ther Targets 2010, 14:243-251.
27. Hunter D., De Lange M., Snieder H., MacGregor A.J., Swaminathan R., Thakker R.V., et al. Genetic contribution to bone metabolism, calcium excretion, and vitamin D and parathyroid hormone regulation. J Bone Miner Res 2001, 16:371-378.
28. Shea M.K., Benjamin E.J., Dupuis J., Massaro J.M., Jacques P.F., D'Agostino R.B., et al. Genetic and non-genetic correlates of vitamins K and D. Eur J Clin Nutr 2009, 63:458-464.
29. Wang T.J., Zhang F., Richards J.B., Kestenbaum B., van Meurs J.B., Berry D., et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 2010, 376:180-188.
30. Cooper J.D., Smyth D.J., Walker N.M., Stevens H., Burren O.S., Wallace C., et al. Inherited variation in vitamin d genes is associated with predisposition to autoimmune disease type 1 diabetes. Diabetes 2011, 60:1624-1631.
31. Goltzman D. Vitamin D action: lessons learned from genetic mouse models. Ann N Y Acad Sci 2010, 1192:145-152.
32. Ramagopalan S.V., Heger A., Berlanga A.J., Maugeri N.J., Lincoln M.R., Burrell A., et al. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res 2010, 20:1352-1360.
33. Somjen D., Weisman Y., Kohen F., Gayer B., Limor R., Sharon O., et al. 25-hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation 2005, 111:1666-1671.
34. Zehnder D., Bland R., Chana R.S., Wheeler D.C., Howie A.J., Williams M.C., et al. Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. J Am Soc Nephrol 2002, 13:621-629.
35. Aihara K., Azuma H., Akaike M., Ikeda Y., Yamashita M., Sudo T., et al. Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice. J Biol Chem 2004, 279:35798-35802.
36. Zittermann A., Schleithoff S.S., Koerfer R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr 2005, 94:483-492.
37. Li Y.C., Kong J., Wei M., Chen Z.F., Liu S.Q., Cao L.P. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002, 110:229-238.
38. Pfeifer M., Begerow B., Minne H.W., Nachtigall D., Hansen C. Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab 2001, 86:1633-1637.
39. Ingles S.A., Haile R.W., Henderson B.E., Kolonel L.N., Nakaichi G., Shi C.Y., et al. Strength of linkage disequilibrium between two vitamin D receptor markers in five ethnic groups: implications for association studies. Cancer Epidemiol Biomarkers Prev 1997, 6:93-98.
40. Ogunkolade B.W., Boucher B.J., Prahl J.M., Bustin S.A., Burrin J.M., Noonan K., et al. Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Diabetes 2002, 51:2294-2300.